March 3-4 (Scientific Program for All Attendees), 2023
Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022. He received his M.S., Ph.D. and M.D. from New York University. Prior to joining Johns Hopkins, he served as director of the Center for Immunological Sciences at the Albert Einstein College of Medicine
Dr. Casadevall’s work has been recognized with numerous awards, including the American Society for Microbiology Founders Distinguished Service Award, the National Institutes of Health Merit Award and the Rhoda Benham Award from Medical Mycology Society of America.
Nate Lawson, DMD, PhD
The rapid increase in outcome studies, use of various outcome terminologies, and inconsistent results have all combined to obscure the actual outcomes of contemporary endodontic treatment modalities. This is confusing to clinicians, and it may act to skew treatment decisions.
To navigate the existing ambiguity, it is necessary to consider the main purposes and stakeholders of treatment outcomes, and the explicit outcome goals that may be set by informed individual patients. This perspective forms the basis for structured methodological appraisal of all published studies, to select those that comprise the CURRENT BEST EVIDENCE for each treatment modality. The longer-term, pertinent outcomes reported in the current best evidence studies are then summarized and effectively communicated to inform treatment decisions.
Following the above strategy, this lecture will highlight the outcomes of endodontic treatment in regard to periapical health, symptom-free function, and survival/retention, based on the current best evidence. Outcome predictors supported by the current best evidence may also be listed.
We will present what takes place around implants with peri-implantitis, and discuss its prevalence and its risks factors. We will compare it to periodontitis and discuss whether or not peri-implantitis is a more severe disease then periodontitis. Based on the available scientific background, we will propose a paradigm shift in the treatment plan of certain implant cases.
Management of endodontically treated teeth has been discussed for decades. Especially, restoring severely compromised tooth structure situations is having many clinical complications and the long-term prognosis is questionable.
Since clinicians have various dowel and core restorative materials, the clinical guideline for selecting appropriate restorative material is essential for the long-term prognosis. This presentation provides the clinical recommendation for selecting dowel and core restorative materials and the modern concept of treatment planning, based on numerous published literature and the presenter’s own research and clinical experiences.
Robert E. Grover, DDS